BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11038121)

  • 1. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours.
    Chandy T; Das GS; Rao GH
    J Microencapsul; 2000; 17(5):625-38. PubMed ID: 11038121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cisplatin delivery due to surface-coated poly (lactic acid)-poly(epsilon-caprolactone) microspheres.
    Chandy T; Wilson RF; Rao GH; Das GS
    J Biomater Appl; 2002 Apr; 16(4):275-91. PubMed ID: 12099508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies.
    Das GS; Rao GH; Wilson RF; Chandy T
    Drug Deliv; 2000; 7(3):129-38. PubMed ID: 10989913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled delivery of taxol from poly(ethylene glycol)-coated poly(lactic acid) microspheres.
    Das GS; Rao GHR ; Wilson RF; Chandy T
    J Biomed Mater Res; 2001 Apr; 55(1):96-103. PubMed ID: 11426403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis.
    Chandy T; Rao GH; Wilson RF; Das GS
    Drug Deliv; 2001; 8(2):77-86. PubMed ID: 11400866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
    Ma G
    J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
    Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
    Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil-loaded chitosan microspheres: preparation and release characteristics.
    Akbuğa J; Bergişadi N
    J Microencapsul; 1996; 13(2):161-8. PubMed ID: 8999121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: characterization and drug release.
    Blanco MD; Sastre RL; Teijón C; Olmo R; Teijón JM
    J Microencapsul; 2005 Sep; 22(6):671-82. PubMed ID: 16401582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer.
    Hussain M; Beale G; Hughes M; Akhtar S
    Int J Pharm; 2002 Mar; 234(1-2):129-38. PubMed ID: 11839444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of 5-fluorouracil-loaded microparticles as biodegradable anticancer drug carriers.
    Boisdron-Celle M; Menei P; Benoit JP
    J Pharm Pharmacol; 1995 Feb; 47(2):108-14. PubMed ID: 7602463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Fluorouracil encapsulated HA/PLGA composite microspheres for cancer therapy.
    Lin Y; Li Y; Ooi CP
    J Mater Sci Mater Med; 2012 Oct; 23(10):2453-60. PubMed ID: 22843166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid tumor chemotherapy and in vivo distribution of fluorouracil following administration in poly(L-lactic acid) microspheres.
    Ciftci K; Hincal AA; Kas HS; Ercan TM; Sungur A; Guven O; Ruacan S
    Pharm Dev Technol; 1997 May; 2(2):151-60. PubMed ID: 9552441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorouracil loaded chitosan microspheres for chemoembolization.
    Denkbaş EB; Seyyal M; Pişkin E
    J Microencapsul; 1999; 16(6):741-9. PubMed ID: 10575626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and release characteristics of polymer-coated and blended alginate microspheres.
    Lee DW; Hwang SJ; Park JB; Park HJ
    J Microencapsul; 2003; 20(2):179-92. PubMed ID: 12554373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
    Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
    Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and release efficiency of polylactic acid nanoparticle].
    Huang KH; Zhu ZH; Liu JH; Chen QK; Liu XY; Chang J
    Ai Zheng; 2005 Aug; 24(8):1023-6. PubMed ID: 16086887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles.
    Yeh MK; Tung SM; Lu DW; Chen JL; Chiang CH
    J Microencapsul; 2001; 18(4):507-19. PubMed ID: 11428679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.